Experimental studies on the tumour inhibitory effect of heparin-degranol (Zitofenton).
D000818:Animals; D002279:Carcinoma 256, Walker / Q000188:drug therapy; D002284:Carcinoma, Brown-Pearce / Q000188:drug therapy; D002286:Carcinoma, Ehrlich Tumor / Q000188:drug therapy; D002455:Cell Division / Q000187:drug effects; D004357:Drug Synergism; D006493:Heparin / Q000008:administration & dosage*; D006496:Heparinoids / Q000008:administration & dosage; D007942:Leukemia, Experimental / Q000188:drug therapy; D008223:Lymphoma / Q000188:drug therapy; D008357:Mannomustine / Q000008:administration & dosage*; D051379:Mice; D009374:Neoplasms, Experimental / Q000188:drug therapy*; D011817:Rabbits; D051381:Rats; D012208:Rhabdomyosarcoma / Q000188:drug therapy; D012510:Sarcoma 180 / Q000188:drug therapy; D012513:Sarcoma, Experimental / Q000188:drug therapy; D012517:Sarcoma, Yoshida / Q000188:drug therapy
D006496:Heparinoids; D006493:Heparin; D008357:Mannomustine